This study aims to investigate the effects of repeated dosing of oral psilocybin on
obsessive-compulsive disorder (OCD) symptomatology in a randomized, waitlist-controlled
design with blinded independent ratings, and assess psychological mechanisms that may mediate
psilocybin's therapeutic effects on OCD.